A Look At The Roles Played By Neurologists Such As Dr. Shiva GopalVasishta In Treating Various Diseases

A new clinical study, HDIT/HCT, which was conducted by the ITN and sponsored by the National Institute of Health (NIH) and NIAID, revealed that stem cell transplants may induce long-term remission of multiple sclerosis (MS). MS is an autoimmune disease where the immune system attacks the central nervous system. The study, which lasted five years, indicated that close to 70 percent of the participants responded positively to the treatment by surviving without progression of disability, brain lesions or relapse of MS symptoms. After receiving HDIT/HCT, these participants did not take any MS treatment. HDIT/HCT research aims to suppress active diseases and prevent further disability by eliminating disease-causing cells and resetting the immune system. This information was originally reported on National Institute of Health as outlined in this link : https://www.crunchbase.com/person/shiva-gopal-vasishta

About Dr. Shiva GopalVasishta

Dr. Shiva GopalVasishta, MD is a renowned Medicare neurology physician in Voorhees, NJ. He is also one of the 34 doctors at Kennedy University Hospital. Neurologists are doctors who diagnose and treat nervous systems disorders, including nerves, spinal cord, and the brain. Neurological diseases involve epilepsy, Parkinson’s disease and Tourette syndrome, which is caused by different illnesses such as Alzheimer’s disease, stroke, or as a result of an accident or brain injury. Dr. Shiva GopalVasishta has extensive experience in the field of neurology. Neurological examination includes evaluations of balance, memory, reflexes and head and neck nerves. These tests primarily involve computed technology (CAT) scans, electroencephalography (EEG) studies and magnetic resonance imaging (MRI).

Dr. Shiva GopalVasishta pursued his medical training at Boston University Medical Center, Government Medical College Nagpur and Tufts Medical Center. He is a member of the Eastern Neurodiagnostic Association, a group practice. The doctor has adequate experience in psychiatry. Over the years, he has been accepting Medicare-approved amount. Dr. Shiva GopalVasishta holds different certifications and licenses, including the American Board of Psychiatry and Neurology and the NJ State Medical License.

Scott Rocklage Leads 5AM Ventures to New Scientific Heights

Scott Rocklage is one of 5AM Ventures’ Managing Partners. He joined the company in 2003 as a partner and later promoted in 2004. With over 20 years of experience in healthcare management and strategic leadership, the Chemistry Ph.D. holder led the company to develop new drugs (Omniscan™, Cubicin®, and Teslascan®) that were later approved by the FDA.

 

Dr. Scott Rocklage has previously worked at Cubist Pharmaceuticals (CEO and Chairman), Nycomed Salutar (President and CEO), and Nycomed Interventional (Chairman, President, and CEO). He had also held several Research and Development positions when he was working at Salutar and Catalytica.

 

Presently, Dr. Rocklage serves as the Board Chairman of Semprus, Achaogen, and Relypsa. Furthermore, he is a board member of Pulmatrix and Variation, WaveRx, and Whitehead Institute. Dr. Rocklage received his B.S. (Chemistry) from University of California-Berkeley. He later attended Massachusetts Institute of Technology for his Chemistry Ph.D. Today, he is based in Waltham, Ma.

 

5AM Ventures

 

5AM Ventures is a successful capital company, which aims to build future generation life science firms with the ability to distribute high profits to its investors. It supports companies that aim to provide solutions to healthcare needs by providing innovations in medicine and science. Furthermore, the venture’s portfolio firms spearhead new methods to diagnose, prevent, and offer treatment to various medical conditions.

 

Board members are also actively involved in the company’s operations as they take up short-term responsibility roles. On the other hand, the company is accountable to all its investors, which allows them to appreciate the amount of work put in to ensure good returns on their investment. 5AM Ventures has centers in the cities of Boston, Massachusetts, and San Francisco, California. It also works with several portfolio companies within the healthcare industry.

 

Practical Approaches that Define the Success Behind 5AM Ventures

 

A hands-on approach to company building: 5AM works diligently with portfolio firms in their early stages by carrying out short-term operating duties and offering practical guidance throughout their life.

 

Teamwork, networking, and broad operational skills: 5AM is capable of recognizing the finest scientists in leading fields, work with specialized entrepreneurs, and co-invest with value-added partners at prominent life science companies.

 

Capital productivity and reduced realization time: 5AM’s prospect involves producing high returns in three to five years.